Quantum-Aided Drug Design from POLARISqb Demonstrates Best-in-Class Capabilities
Polaris Quantum Biotech (POLARISqb), the leader in quantum computing-based drug design, announced the development of Quantum-Aided Drug Design (QuADD) for molecular library optimization in April 2023. QuADD runs on quantum computers that solve problems with unprecedented speed and power, allowing users to search a chemical space of more than 1030 molecules for those that complement…
